Keywords: Cornerstone Thera, EKR Thera, M&S, Acute-care hospital products, Cardiovascular

Cornerstone makes $125 million, plus, bid for EKR Thera

Article | 16 May 2012

Print This

In a second acquisition move within a matter of months, USA-based specialty drugmaker Cornerstone Therapeutics has made a takeover bid ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in